Europe Peptide Vaccine Market Report 2017

Europe Peptide Vaccine Market Report 2017

1 Peptide Vaccine Overview

1.1 Product Overview and Scope of Peptide Vaccine

1.2 Classification of Peptide Vaccine

1.2.1 Type I

1.2.2 Type II

1.3 Application of Peptide Vaccine

1.3.1 Application 1

1.3.2 Application 2

1.4 Peptide Vaccine Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of Peptide Vaccine (2012-2022)

1.5.1 Europe Peptide Vaccine Sales and Growth Rate (2012-2022)

1.5.2 Europe Peptide Vaccine Revenue and Growth Rate (2012-2022)

2 Europe Peptide Vaccine by Manufacturers, Type and Application

2.1 Europe Peptide Vaccine Market Competition by Manufacturers

2.1.1 Europe Peptide Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Peptide Vaccine Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Peptide Vaccine (Volume and Value) by Type

2.2.1 Europe Peptide Vaccine Sales and Market Share by Type (2012-2017)

2.2.2 Europe Peptide Vaccine Revenue and Market Share by Type (2012-2017)

2.3 Europe Peptide Vaccine (Volume and Value) by Countries

2.3.1 Europe Peptide Vaccine Sales and Market Share by Countries (2012-2017)

2.3.2 Europe Peptide Vaccine Revenue and Market Share by Countries (2012-2017)

2.4 Europe Peptide Vaccine (Volume) by Application

3 Germany Peptide Vaccine (Volume, Value and Sales Price)

3.1 Germany Peptide Vaccine Sales and Value (2012-2017)

3.1.1 Germany Peptide Vaccine Sales and Growth Rate (2012-2017)

3.1.2 Germany Peptide Vaccine Revenue and Growth Rate (2012-2017)

3.1.3 Germany Peptide Vaccine Sales Price Trend (2012-2017)

3.2 Germany Peptide Vaccine Sales and Market Share by Manufacturers

3.3 Germany Peptide Vaccine Sales and Market Share by Type

3.4 Germany Peptide Vaccine Sales and Market Share by Application

4 France Peptide Vaccine (Volume, Value and Sales Price)

4.1 France Peptide Vaccine Sales and Value (2012-2017)

4.1.1 France Peptide Vaccine Sales and Growth Rate (2012-2017)

4.1.2 France Peptide Vaccine Revenue and Growth Rate (2012-2017)

4.1.4 France Peptide Vaccine Sales Price Trend (2012-2017)

4.2 France Peptide Vaccine Sales and Market Share by Manufacturers

4.3 France Peptide Vaccine Sales and Market Share by Type

4.4 France Peptide Vaccine Sales and Market Share by Application

5 UK Peptide Vaccine (Volume, Value and Sales Price)

5.1 UK Peptide Vaccine Sales and Value (2012-2017)

5.1.1 UK Peptide Vaccine Sales and Growth Rate (2012-2017)

5.1.2 UK Peptide Vaccine Revenue and Growth Rate (2012-2017)

5.1.5 UK Peptide Vaccine Sales Price Trend (2012-2017)

5.2 UK Peptide Vaccine Sales and Market Share by Manufacturers

5.3 UK Peptide Vaccine Sales and Market Share by Type

5.4 UK Peptide Vaccine Sales and Market Share by Application

6 Russia Peptide Vaccine (Volume, Value and Sales Price)

6.1 Russia Peptide Vaccine Sales and Value (2012-2017)

6.1.1 Russia Peptide Vaccine Sales and Growth Rate (2012-2017)

6.1.2 Russia Peptide Vaccine Revenue and Growth Rate (2012-2017)

6.1.6 Russia Peptide Vaccine Sales Price Trend (2012-2017)

6.2 Russia Peptide Vaccine Sales and Market Share by Manufacturers

6.3 Russia Peptide Vaccine Sales and Market Share by Type

6.4 Russia Peptide Vaccine Sales and Market Share by Application

7 Italy Peptide Vaccine (Volume, Value and Sales Price)

7.1 Italy Peptide Vaccine Sales and Value (2012-2017)

7.1.1 Italy Peptide Vaccine Sales and Growth Rate (2012-2017)

7.1.2 Italy Peptide Vaccine Revenue and Growth Rate (2012-2017)

7.1.7 Italy Peptide Vaccine Sales Price Trend (2012-2017)

7.2 Italy Peptide Vaccine Sales and Market Share by Manufacturers

7.3 Italy Peptide Vaccine Sales and Market Share by Type

7.4 Italy Peptide Vaccine Sales and Market Share by Application

8 Spain Peptide Vaccine (Volume, Value and Sales Price)

8.1 Spain Peptide Vaccine Sales and Value (2012-2017)

8.1.1 Spain Peptide Vaccine Sales and Growth Rate (2012-2017)

8.1.2 Spain Peptide Vaccine Revenue and Growth Rate (2012-2017)

8.1.8 Spain Peptide Vaccine Sales Price Trend (2012-2017)

8.2 Spain Peptide Vaccine Sales and Market Share by Manufacturers

8.3 Spain Peptide Vaccine Sales and Market Share by Type

8.4 Spain Peptide Vaccine Sales and Market Share by Application

9 Benelux Peptide Vaccine (Volume, Value and Sales Price)

9.1 Benelux Peptide Vaccine Sales and Value (2012-2017)

9.1.1 Benelux Peptide Vaccine Sales and Growth Rate (2012-2017)

9.1.2 Benelux Peptide Vaccine Revenue and Growth Rate (2012-2017)

9.1.9 Benelux Peptide Vaccine Sales Price Trend (2012-2017)

9.2 Benelux Peptide Vaccine Sales and Market Share by Manufacturers

9.3 Benelux Peptide Vaccine Sales and Market Share by Type

9.4 Benelux Peptide Vaccine Sales and Market Share by Application

10 Europe Peptide Vaccine Manufacturers Analysis

10.1 Artificial Cell Technologies

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Peptide Vaccine Product Type, Application and Specification

10.1.2.1 Product A

10.1.2.2 Product B

10.1.3 Artificial Cell Technologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Benovus Bio

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Peptide Vaccine Product Type, Application and Specification

10.2.2.1 Product A

10.2.2.2 Product B

10.2.3 Benovus Bio Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Bionor Pharma

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Peptide Vaccine Product Type, Application and Specification

10.3.2.1 Product A

10.3.2.2 Product B

10.3.3 Bionor Pharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Circassia

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Peptide Vaccine Product Type, Application and Specification

10.4.2.1 Product A

10.4.2.2 Product B

10.4.3 Circassia Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Celgene Corporation

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Peptide Vaccine Product Type, Application and Specification

10.5.2.1 Product A

10.5.2.2 Product B

10.5.3 Celgene Corporation Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 Galena Biopharma

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Peptide Vaccine Product Type, Application and Specification

10.6.2.1 Product A

10.6.2.2 Product B

10.6.3 Galena Biopharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Immatics biotechnologies

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Peptide Vaccine Product Type, Application and Specification

10.7.2.1 Product A

10.7.2.2 Product B

10.7.3 Immatics biotechnologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 Immune Design

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Peptide Vaccine Product Type, Application and Specification

10.8.2.1 Product A

10.8.2.2 Product B

10.8.3 Immune Design Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

10.9 ImmunoCellular Therapeutics

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Peptide Vaccine Product Type, Application and Specification

10.9.2.1 Product A

10.9.2.2 Product B

10.9.3 ImmunoCellular Therapeutics Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.9.4 Main Business/Business Overview

10.10 Invectys

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Peptide Vaccine Product Type, Application and Specification

10.10.2.1 Product A

10.10.2.2 Product B

10.10.3 Invectys Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

10.10.4 Main Business/Business Overview

10.11 ISA Pharmaceuticals

10.12 Lytix Biopharma

10.13 Medinet

10.14 Memcine Pharmaceuticals

10.15 Merck Serono

10.16 OncoTherapy Science

11 Peptide Vaccine Manufacturing Cost Analysis

11.1 Peptide Vaccine Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Peptide Vaccine

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Peptide Vaccine Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Peptide Vaccine Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Peptide Vaccine Market Forecast (2017-2022)

14.1 Germany Peptide Vaccine Sales Forecast (2017-2022)

14.2 France Peptide Vaccine Sales Forecast (2017-2022)

14.3 UK Peptide Vaccine Sales Forecast (2017-2022)

14.4 Russia Peptide Vaccine Sales Forecast (2017-2022)

14.5 Italy Peptide Vaccine Sales Forecast (2017-2022)

14.6 Spain Peptide Vaccine Sales Forecast (2017-2022)

14.7 Benelux Peptide Vaccine Sales Forecast (2017-2022)

14.8 Europe Peptide Vaccine Sales Forecast by Type (2017-2022)

14.9 Europe Peptide Vaccine Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Peptide Vaccine

Table Classification of Peptide Vaccine

Figure Europe Sales Market Share of Peptide Vaccine by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of Peptide Vaccine

Figure Europe Sales Market Share of Peptide Vaccine by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure France Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure UK Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure Russia Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure Italy Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure Spain Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure Benelux Peptide Vaccine Revenue and Growth Rate (2012-2022)

Figure Europe Peptide Vaccine Sales and Growth Rate (2012-2022)

Figure Europe Peptide Vaccine Revenue and Growth Rate (2012-2022)

Table Europe Peptide Vaccine Sales of Key Manufacturers (2015 and 2016)

Table Europe Peptide Vaccine Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Peptide Vaccine Sales Share by Manufacturers

Figure 2016 Peptide Vaccine Sales Share by Manufacturers

Table Europe Peptide Vaccine Revenue by Manufacturers (2015 and 2016)

Table Europe Peptide Vaccine Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Peptide Vaccine Revenue Share by Manufacturers

Table 2016 Europe Peptide Vaccine Revenue Share by Manufacturers

Table Europe Peptide Vaccine Sales and Market Share by Type (2012-2017)

Table Europe Peptide Vaccine Sales Share by Type (2012-2017)

Figure Sales Market Share of Peptide Vaccine by Type (2012-2017)

Figure Europe Peptide Vaccine Sales Growth Rate by Type (2012-2017)

Table Europe Peptide Vaccine Revenue and Market Share by Type (2012-2017)

Table Europe Peptide Vaccine Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Peptide Vaccine by Type (2012-2017)

Figure Europe Peptide Vaccine Revenue Growth Rate by Type (2012-2017)

Table Europe Peptide Vaccine Sales and Market Share by Countries (2012-2017)

Table Europe Peptide Vaccine Sales Share by Countries (2012-2017)

Figure Sales Market Share of Peptide Vaccine by Countries (2012-2017)

Table Europe Peptide Vaccine Revenue and Market Share by Countries (2012-2017)

Table Europe Peptide Vaccine Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Peptide Vaccine by Countries (2012-2017)

Table Europe Peptide Vaccine Sales and Market Share by Application (2012-2017)

Table Europe Peptide Vaccine Sales Share by Application (2012-2017)

Figure Sales Market Share of Peptide Vaccine by Application (2012-2017)

Figure Germany Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure Germany Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure Germany Peptide Vaccine Sales Price Trend (2012-2017)

Table Germany Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table Germany Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table Germany Peptide Vaccine Sales by Type (2015 and 2016)

Table Germany Peptide Vaccine Market Share by Type (2015 and 2016)

Table Germany Peptide Vaccine Sales by Application (2015 and 2016)

Table Germany Peptide Vaccine Market Share by Application (2015 and 2016)

Figure France Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure France Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure France Peptide Vaccine Sales Price Trend (2012-2017)

Table France Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table France Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table France Peptide Vaccine Sales by Type (2015 and 2016)

Table France Peptide Vaccine Market Share by Type (2015 and 2016)

Table France Peptide Vaccine Sales by Application (2015 and 2016)

Table France Peptide Vaccine Market Share by Application (2015 and 2016)

Figure UK Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure UK Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure UK Peptide Vaccine Sales Price Trend (2012-2017)

Table UK Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table UK Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table UK Peptide Vaccine Sales by Type (2015 and 2016)

Table UK Peptide Vaccine Market Share by Type (2015 and 2016)

Table UK Peptide Vaccine Sales by Application (2015 and 2016)

Table UK Peptide Vaccine Market Share by Application (2015 and 2016)

Figure Russia Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure Russia Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure Russia Peptide Vaccine Sales Price Trend (2012-2017)

Table Russia Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table Russia Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table Russia Peptide Vaccine Sales by Type (2015 and 2016)

Table Russia Peptide Vaccine Market Share by Type (2015 and 2016)

Table Russia Peptide Vaccine Sales by Application (2015 and 2016)

Table Russia Peptide Vaccine Market Share by Application (2015 and 2016)

Figure Italy Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure Italy Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure Italy Peptide Vaccine Sales Price Trend (2012-2017)

Table Italy Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table Italy Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table Italy Peptide Vaccine Sales by Type (2015 and 2016)

Table Italy Peptide Vaccine Market Share by Type (2015 and 2016)

Table Italy Peptide Vaccine Sales by Application (2015 and 2016)

Table Italy Peptide Vaccine Market Share by Application (2015 and 2016)

Figure Spain Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure Spain Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure Spain Peptide Vaccine Sales Price Trend (2012-2017)

Table Spain Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table Spain Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table Spain Peptide Vaccine Sales by Type (2015 and 2016)

Table Spain Peptide Vaccine Market Share by Type (2015 and 2016)

Table Spain Peptide Vaccine Sales by Application (2015 and 2016)

Table Spain Peptide Vaccine Market Share by Application (2015 and 2016)

Figure Benelux Peptide Vaccine Sales and Growth Rate (2012-2017)

Figure Benelux Peptide Vaccine Revenue and Growth Rate (2012-2017)

Figure Benelux Peptide Vaccine Sales Price Trend (2012-2017)

Table Benelux Peptide Vaccine Sales by Manufacturers (2015 and 2016)

Table Benelux Peptide Vaccine Market Share by Manufacturers (2015 and 2016)

Table Benelux Peptide Vaccine Sales by Type (2015 and 2016)

Table Benelux Peptide Vaccine Market Share by Type (2015 and 2016)

Table Benelux Peptide Vaccine Sales by Application (2015 and 2016)

Table Benelux Peptide Vaccine Market Share by Application (2015 and 2016)

Table Peptide Vaccine Basic Information List

Table Artificial Cell Technologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Artificial Cell Technologies Peptide Vaccine Sales Market Share (2012-2017)

Table Benovus Bio Basic Information List

Table Benovus Bio Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Benovus Bio Peptide Vaccine Sales Market Share (2012-2017)

Table Bionor Pharma Basic Information List

Table Bionor Pharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bionor Pharma Peptide Vaccine Sales Market Share (2012-2017)

Table Circassia Basic Information List

Table Circassia Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Circassia Peptide Vaccine Sales Market Share (2012-2017)

Table Celgene Corporation Basic Information List

Table Celgene Corporation Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Celgene Corporation Peptide Vaccine Sales Market Share (2012-2017)

Table Galena Biopharma Basic Information List

Table Galena Biopharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Galena Biopharma Peptide Vaccine Sales Market Share (2012-2017)

Table Immatics biotechnologies Basic Information List

Table Immatics biotechnologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Immatics biotechnologies Peptide Vaccine Sales Market Share (2012-2017)

Table Immune Design Basic Information List

Table Immune Design Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Immune Design Peptide Vaccine Sales Market Share (2012-2017)

Table ImmunoCellular Therapeutics Basic Information List

Table ImmunoCellular Therapeutics Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table ImmunoCellular Therapeutics Peptide Vaccine Sales Market Share (2012-2017)

Table Invectys Basic Information List

Table Invectys Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

Table Invectys Peptide Vaccine Sales Market Share (2012-2017)

Table ISA Pharmaceuticals Basic Information List

Table Lytix Biopharma Basic Information List

Table Medinet Basic Information List

Table Memcine Pharmaceuticals Basic Information List

Table Merck Serono Basic Information List

Table OncoTherapy Science Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Peptide Vaccine

Figure Manufacturing Process Analysis of Peptide Vaccine

Figure Peptide Vaccine Industrial Chain Analysis

Table Raw Materials Sources of Peptide Vaccine Major Manufacturers in 2015

Table Major Buyers of Peptide Vaccine

Table Distributors/Traders List

Figure Germany Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure Germany Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Figure France Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure France Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Figure UK Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure UK Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Figure Russia Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure Russia Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Figure Italy Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure Italy Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Figure Spain Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure Spain Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)

Figure Benelux Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)

Table Europe Peptide Vaccine Sales Forecast by Type (2017-2022)

Table Europe Peptide Vaccine Sales Forecast by Application (2017-2022)